ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LPL Financial LLC 18,879$507,2790.00%
ENVESTNET ASSET MANAGEMENT INC 8,442$226,8300.00%
Citadel Advisors 65,600$1,762,6720.00%
Citadel Advisors 34,000$913,5800.00%
Baker Avenue Asset Management, LP 172$4,6220.00%
BESSEMER GROUP INC 13$00.00%
SIGNATUREFD, LLC 109$2,9290.00%
JFS WEALTH ADVISORS, LLC 96$2,5800.00%
FinTrust Capital Advisors, LLC 37$1,0040.00%
TFO Wealth Partners, LLC 5$1780.00%
Itau Unibanco Holding S.A. 175$4,7020.00%
Steward Partners Investment Advisory, LLC 205$5,5080.00%
Allspring Global Investments Holdings, LLC 5,966$160,3060.00%
MASSMUTUAL TRUST CO FSB/ADV 63$1,6930.00%
GPS Wealth Strategies Group, LLC 18$4840.00%
Point72 Asset Management, L.P. 811$21,7920.00%
FARMERS & MERCHANTS INVESTMENTS INC 50$1,3440.00%
Bell Investment Advisors, Inc 17$4570.00%
LAZARD ASSET MANAGEMENT LLC 4,018$1070.00%
External links

This page lists ARROWHEAD PHARMACEUTICALS IN's shareholders in Q3 2023. To view ARROWHEAD PHARMACEUTICALS IN's shareholder history, click here.